Announcements
Sidley Advises PhaseV in Its US$50 Million Series A Financing
May 14, 2025
Sidley advised PhaseV Trials Inc., a leader in AI/ML-driven clinical development, in its US$50 million Series A financing round. The round was co-led by Accel and Insight Partners, with participation from Viola Ventures, Exor Ventures, and LionBird.
For additional information, please refer to the press release.
The Sidley team was led by Dr. Idan Netser and Jake Funk (Emerging Companies and Venture Capital).
連絡先
得意分野
Suggested News & Insights
Sidley Represents Cymphony in Its US$30 Million Series A FinancingSeptember 18, 2026When the Meeting Minutes and the AI Transcript Don’t Match: Litigation Insights From Delaware ChancerySeptember 17, 2026Sidley Represents Noetive in US$41 Million Series Seed FinancingSeptember 17, 2026Sidley Represents Verily Health in Investment from NVIDIASeptember 11, 2026The Evolving Regulatory Landscape for Private Credit: Key Considerations for LendersSeptember 3, 2026Sidley Represents Werewolf Therapeutics in Merger with Ambros Therapeutics and Concurrent US$150 Million Private PlacementAugust 21, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory